These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10492 related articles for article (PubMed ID: 12567765)

  • 1. [Correlations of Ki-67 expression and histopathologic characteristics in uveal melanomas].
    Liang J; Yi C; Schilling H; Li X
    Yan Ke Xue Bao; 2001 Jun; 17(2):114-7, 132. PubMed ID: 12567765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
    Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
    Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
    Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques.
    Schilling H; Sehu KW; Lee WR
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2081-92. PubMed ID: 9331272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.
    Mooy CM; de Jong PT; Van der Kwast TH; Mulder PG; Jager MJ; Ruiter DJ
    Ophthalmology; 1990 Oct; 97(10):1275-80. PubMed ID: 2243677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.
    Karlsson M; Boeryd B; Carstensen J; Frånlund B; Gustafsson B; Kågedal B; Sun XF; Wingren S
    Eur J Cancer; 1996 Feb; 32A(2):357-62. PubMed ID: 8664054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
    Pe'er J; Gnessin H; Shargal Y; Livni N
    Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
    Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid.
    Chowers I; Folberg R; Livni N; Pe'er J
    Curr Eye Res; 2002 Feb; 24(2):105-8. PubMed ID: 12187481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation among different immunostaining evaluation methods for the assessment of proliferative activity in uveal melanoma.
    Chowers I; Amer R; Pe'er J
    Curr Eye Res; 2002 Dec; 25(6):369-72. PubMed ID: 12789544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HLA class I antigen expression correlates with histological cell type in uveal melanoma].
    Dithmar S; Crowder J; Jager MJ; Vigniswaran N; Grossniklaus HE
    Ophthalmologe; 2002 Aug; 99(8):625-8. PubMed ID: 12227276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transscleral optical spectroscopy of uveal melanoma in enucleated human eyes.
    Krohn J; Svenmarker P; Xu CT; Mørk SJ; Andersson-Engels S
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5379-85. PubMed ID: 22729436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor-A, matrix metalloproteinase-9, and extravascular matrix patterns and their correlations with clinicopathologic parameters in posterior uveal melanomas.
    Sahin A; Kiratli H; Soylemezoglu F; Tezel GG; Bilgic S; Saracbasi O
    Jpn J Ophthalmol; 2007; 51(5):325-331. PubMed ID: 17926107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of uveal melanoma growth rates with mitotic index and mortality.
    Gass JD
    Arch Ophthalmol; 1985 Jul; 103(7):924-31. PubMed ID: 4015483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of inflammatory cells in uveal melanoma after prior irradiation.
    Vu TH; Bronkhorst IH; Versluis M; Marinkovic M; van Duinen SG; Vrolijk J; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):360-9. PubMed ID: 23211827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expression in uveal malignant melanomas.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas].
    Krvavica A; Talan-Hranilović J; Belicza M
    Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 525.